Switching from calcium carbonate to sevelamer hydrochloride has suppressive effects on the progression of aortic calcificationin hemodialysis patients: Assessment using plain chest X-ray films

Renal Failure

Volumn 30, Issue 10, 2008, Pages 952-958

  Izumi, Masaaki ^a   Morita, Syunpei ^b   Nishian, Yoshihiko ^b   Miyamoto, Takashi ^b   Kasumoto, Hiroomi ^c   Oue, Mai ^a   Hori, Kahori ^a   Kitamura, Rie ^a   Yamamoto, Satoshi ^a   Nakanishi, Takeshi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Miyamoto Clinic   (Japan)

^c Meiwa Hospital   (Japan)

Author keywords

Aortic arch; Calcium carbonate; Chest X ray; Sevelamer hydrochloride; Vascular calcification

Indexed keywords

CALCIUM CARBONATE; PHOSPHATE BINDING AGENT; SEVELAMER;

ADULT; AORTA CALCIFICATION; AORTA OCCLUSION; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DIAGNOSTIC IMAGING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYDROGEL; IMAGE ANALYSIS; MALE; MEDICAL ASSESSMENT; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

AGED; ANTACIDS; AORTIC DISEASES; CALCINOSIS; CALCIUM CARBONATE; CHELATING AGENTS; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYAMINES; RADIOGRAPHY, THORACIC; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 57049092872     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802381893     Document Type: Article

References (27)

1. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478-1483.
2. Foley RN, Patrick MB, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis. 1998;32 (Suppl. 3):S112-S119.
3. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100-105.
4. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938-942.
5. London GM. Cardiovascular calcification in uremic patients: Clinical impact on cardiovascular function. J Am Soc Nephrol. 2003;14:S305-S309.
6. Chertow GM, Burke SK, Raggi P, for the Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245-252.
7. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Determinants of progressive vascular calcification in hemodialysis patients. Nephrol Dial Transplant. 2004;19:1489-1496.
8. Asmus HG, Braun J, Krause R, et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant. 2005;20:1653-1661.
9. Moe SM, O'Neill KD, Fineberg N, et al. Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant. 2003;18:1152-1158.
10. Moe SM, O'Neill KD, Resterova M, Fineberg N, Persohn S, Meyer CA. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant. 2004; 19: 2387-2393.
11. Krasniak A, Drozdz M, Pasowicz M, et al. Factors involved in vascular calcification and atherosclerosis in maintenance hemodialysis patents. Nephrol Dial Transplant. 2007; 22: 515-521.
12. Hashiba H, Aizawa S, Tamura K, Kogo H. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: Long-term effects. Ther Apher Dial. 2006;10:59-64.
13. Taniwaki H, Ishimura E, Tabata T, et al. Aortic calcification in hemodialysis patients with diabetes mellitus. Nephrol Dial Transplant. 2005;20:2472-2478.
14. Kabaya T, Nitta K, Kimura H, Kawashima A, Narusawa K, Nihei H. Increased aortic calcification index in hemodialysis patients. Nephron. 1999;81:354-355.
15. Kushiya F, Wada H, Sakakura M, et al. Prognostic impact of aortic calcification index and ankle-arm blood pressure index in patients under hemodialysis. Clin Appl Thromb Hemost. 2005;11:161-169.
16. Kimura K, Saika Y, Otani H, Fujii R, Mune M, Yukawa S. Factors associated with calcification of the abdominal aorta in hemodialysis patients. Kidney Int. 1999;56 (Suppl. 71):S238-S241.
17. Tamura K, Hashiba H, Kogo H, Aizawa S, Shigematsu T. Suppressive effects of bisphosphonates on the vascular calcification in ESRD patients. Clin Calcium. 2002;12:1129-1135.
18. Chertow GM, Burke SK, Dillon MA, Slatopolsky E; for the RenaGel Study Group. Long term effects of sevelamer hydrochloride on the calciumxphosphate product and lipid profile of hemodialysis patients. Nephrol Dial Transplant. 1999;14:2907-2914.
19. Patient Registration Committee, Japanese Society of Dialysis Therapy, Tokyo, Japan. An overview of regular dialysis treatment in Japan as of 31 December 2003. Ther Apher Dial. 2005;9:431-458.
20. Cozzolino M, Staniforth ME, Liapis H et al. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int. 2003;64:1653-1661.
21. Katsumata K, Kusano K, Hirata M, et al. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int. 2003; 64: 441-450.
22. Muntner P, Ferramosca E, Bellasi A, Block GA, Raggi P. Development of a cardiovascular calcification index using simple imaging tools in hemodialysis patients. Nephrol Dial Transplant. 2007;22:508-514.
23. Fabbian F, Catalano C, Orlandi V, Conte MM, Lupo A, Catizone L. Evaluation of aortic arch calcification in hemodialysis patients. J Nephrol. 2005;18:289-293.
24. Shigematsu T, Kono T, Satoh K, et al. Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients. Nephrol Dial Transplant. 2003;18 (Suppl. 3): iii86-iii89.
25. Nikolov I, Joki N, Drueke T, Massy Z. Beyond phosphate-role of uremic toxins in cardiovascular calcification. Nephrol Dial Transplant. 2006;21:3354-3357.
26. Oka Y, Miyazaki M, Takatsu S, et al. Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage. Ther Apher Dial. 2007;11:107-113.
27. Picolos MK, Orlander PR. Calcium carbonate toxicity: The updated milk-alkali syndrome: Report of three cases and review of the literature. Endocr Pract. 2005;11:272-280.